Dimensional Fund Advisors’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,242,474
| Closed | -$11.4M | – | 3564 |
|
|
2021
Q2 | $11.4M | Buy |
1,242,474
+67,495
| +6% | +$393K | ﹤0.01% | 2299 |
|
|
2021
Q1 | $5.83M | Sell |
1,174,979
-13,906
| -1% | -$67.2K | ﹤0.01% | 2525 |
|
|
2020
Q4 | $5.12M | Sell |
1,188,885
-37,539
| -3% | -$153K | ﹤0.01% | 2517 |
|
|
2020
Q3 | $5.26M | Sell |
1,226,424
-13,647
| -1% | -$57K | ﹤0.01% | 2434 |
|
|
2020
Q2 | $5.57M | Sell |
1,240,071
-74,004
| -6% | -$331K | ﹤0.01% | 2446 |
|
|
2020
Q1 | $5.26M | Sell |
1,314,075
-17,769
| -1% | -$151K | ﹤0.01% | 2384 |
|
|
2019
Q4 | $11.3M | Sell |
1,331,844
-5,682
| -0.4% | -$44.3K | ﹤0.01% | 2303 |
|
|
2019
Q3 | $9.16M | Buy |
1,337,526
+8,890
| +0.7% | +$65.2K | ﹤0.01% | 2376 |
|
|
2019
Q2 | $11.1M | Sell |
1,328,636
-17,615
| -1% | -$152K | ﹤0.01% | 2361 |
|
|
2019
Q1 | $12.3M | Sell |
1,346,251
-36,394
| -3% | -$370K | ﹤0.01% | 2313 |
|
|
2018
Q4 | $15.1M | Buy |
1,382,645
+32,834
| +2% | +$414K | 0.01% | 2139 |
|
|
2018
Q3 | $18.8M | Buy |
1,349,811
+3,839
| +0.3% | +$51.9K | 0.01% | 2154 |
|
|
2018
Q2 | $14.3M | Sell |
1,345,972
-19,030
| -1% | -$186K | 0.01% | 2265 |
|
|
2018
Q1 | $11.8M | Buy |
1,365,002
+5,587
| +0.4% | +$49K | ﹤0.01% | 2310 |
|
|
2017
Q4 | $12.8M | Buy |
1,359,415
+2,945
| +0.2% | +$23K | 0.01% | 2273 |
|
|
2017
Q3 | $10.6M | Sell |
1,356,470
-12,754
| -0.9% | -$95.7K | ﹤0.01% | 2354 |
|
|
2017
Q2 | $11.8M | Sell |
1,369,224
-464
| -0% | -$3.33K | 0.01% | 2277 |
|
|
2017
Q1 | $9.66M | Buy |
1,369,688
+34,735
| +3% | +$218K | ﹤0.01% | 2341 |
|
|
2016
Q4 | $5.67M | Buy |
1,334,953
+1,310,155
| +5,283% | +$6.34M | ﹤0.01% | 2510 |
|
|
2016
Q3 | $123K | Buy |
24,798
+2,044
| +9% | +$8.64K | ﹤0.01% | 3220 |
|
|
2016
Q2 | $81K | Buy |
22,754
+11,682
| +106% | +$42.9K | ﹤0.01% | 3243 |
|
|
2016
Q1 | $38K | Hold |
11,072
| – | – | ﹤0.01% | 3273 |
|
|
2015
Q4 | $38K | Buy |
11,072
+900
| +9% | +$4.17K | ﹤0.01% | 3306 |
|
|
2015
Q3 | $53K | Buy |
+10,172
| New | +$62.7K | ﹤0.01% | 3339 |
|
Other funds holding KIN
Dimensional Fund Advisors's KIN Position: Q3 2021 in Review
Dimensional Fund Advisors sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 1,242,474 shares — an estimated $11.4M sold.
Dimensional Fund Advisors first reported a position in KIN in Q3 2015 and held it in 24 quarters. The position peaked at $18.8M in Q3 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Dimensional Fund Advisors reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Dimensional Fund Advisors sold 1,242,474 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $11.4M.
- Dimensional Fund Advisors first reported a position in Kindred Biosciences, Inc. in Q3 2015 and held it in 24 quarters.
- Dimensional Fund Advisors's Kindred Biosciences, Inc. position peaked at $18.8M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Dimensional Fund Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.